Grace Therapeutics (GRCE) Payables (2012 - 2026)
Grace Therapeutics' Payables came in at $1.61 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 29.6% from $1.25 million a year earlier and up 29.1% from the prior quarter.
Grace Therapeutics (GRCE) Payables (2012 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Grace Therapeutics' Payables was $2.15 million, up 11.2% from FY2025.
- Payables carries a five-year compound annual growth rate of 7.5% (FY2021 to FY2026).
- Going back by fiscal year, Payables was $1.93 million in FY2025 (+14.6%), $1.68 million in FY2024 (-50.6%), $3.41 million in FY2023 (+8.1%) and $3.16 million in FY2022 (+111.4%).
- The five-year range for quarterly Payables is $1.25 million (fiscal Q2 2026) to $3.74 million (fiscal Q2 2023).
- Year-over-year, Payables increased in four of the last eight quarters, with an average decline of 9.8%.
- The fastest year-over-year change in Payables over five years came in fiscal Q4 2022 (growth of 111.4%), and the weakest in fiscal Q2 2024 (a decline of 63.8%).
- Business Quant data shows GRCE's Payables at $1.25 million (Q1 2027), $2.15 million (Q4 2026) and $1.28 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | -24.05 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Grace Therapeutics | 35.10 Mn | -35.61 Mn | - | 1.61 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.61 Mn |
| Jun 30, 2026 | 1.25 Mn |
| Mar 31, 2026 | 2.15 Mn |
| Dec 31, 2025 | 1.28 Mn |
| Sep 30, 2025 | 1.25 Mn |
| Jun 30, 2025 | 2.32 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | 2.60 Mn |
| Mar 31, 2024 | 1.68 Mn |
| Dec 31, 2023 | 1.77 Mn |
| Sep 30, 2023 | 1.35 Mn |
| Jun 30, 2023 | 1.89 Mn |
| Mar 31, 2023 | 3.41 Mn |
| Dec 31, 2022 | 3.36 Mn |
| Sep 30, 2022 | 3.74 Mn |
| Jun 30, 2022 | 3.06 Mn |
| Mar 31, 2022 | 3.16 Mn |
| Dec 31, 2021 | 2.84 Mn |
Grace Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=GRCE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();